Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Transplant patients often get skin problems, with treatments varying by condition.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Proper care and diet are crucial to prevent health issues in gerbils.

Histone modification is key in treating chronic inflammatory skin diseases.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Sudden, unusual hair loss may indicate serious underlying health issues.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Cyclosporin doesn't stop hair loss.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Terbinafine can cause hair loss.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.